Certara is adding deep learning capabilities to D360. The addition of novel A.I. will enable discovery scientists to integrate multiple structured and unstructured data sources and substantially enhance predictions and analysis of content related to small molecules and biologic drugs for accelerated, high confidence decisions.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CERT: